PPCB
Propanc Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · AU
$1.01
−0.98%Leverage
- Debt / equity
- 0.16x
- Net debt / equity
- 0.11x
- Debt / assets
- 0.11x
- Debt / EBITDA
- -0.09x
- Net debt / EBITDA
- -0.06x
Liquidity & coverage
- Current ratio
- 2.37x
- Quick ratio
- 2.37x
- Cash ratio
- 0.13x
- Interest coverage
- -27.95x
- EBITDA / interest
- -26.90x
- Working capital
- $4.7M
Cash & dividend
- FCF / debt
- -2.61x
- Cash flow / debt
- -2.61x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026